FOLH1 and prostate carcinoma: Pioneering clinical studies initially demonstrated that RT-PCR for PSMA in whole blood from patients with prostatic pathology was moderately sensitive and highly specific for neoplasia, and this early research showed a correlation between circulating prostatic carcinoma cells and metastasis.